107 related articles for article (PubMed ID: 11390357)
1. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects.
Filleur S; Volpert OV; Degeorges A; Voland C; Reiher F; Clézardin P; Bouck N; Cabon F
Genes Dev; 2001 Jun; 15(11):1373-82. PubMed ID: 11390357
[TBL] [Abstract][Full Text] [Related]
2. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.
Volpert OV; Lawler J; Bouck NP
Proc Natl Acad Sci U S A; 1998 May; 95(11):6343-8. PubMed ID: 9600967
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells.
Tenan M; Fulci G; Albertoni M; Diserens AC; Hamou MF; El Atifi-Borel M; Feige JJ; Pepper MS; Van Meir EG
J Exp Med; 2000 May; 191(10):1789-98. PubMed ID: 10811871
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.
Choi SH; Tamura K; Khajuria RK; Bhere D; Nesterenko I; Lawler J; Shah K
Mol Ther; 2024 May; 32(5):1595. PubMed ID: 38702134
[No Abstract] [Full Text] [Related]
5. PP2A Affects Angiogenesis via Its Interaction with a Novel Phosphorylation Site of TSP1.
Thalwieser Z; Fonódi M; Király N; Csortos C; Boratkó A
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339122
[TBL] [Abstract][Full Text] [Related]
6. The evolving role of thrombospondin-1 in hemostasis and vascular biology.
Bonnefoy A; Moura R; Hoylaerts MF
Cell Mol Life Sci; 2008 Mar; 65(5):713-27. PubMed ID: 18193161
[TBL] [Abstract][Full Text] [Related]
7. Role of thrombospondin 1 in liver diseases.
Li Y; Turpin CP; Wang S
Hepatol Res; 2017 Feb; 47(2):186-193. PubMed ID: 27492250
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 in vascular development, vascular function, and vascular disease.
Liu B; Yang H; Song YS; Sorenson CM; Sheibani N
Semin Cell Dev Biol; 2024 Mar; 155(Pt B):32-44. PubMed ID: 37507331
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF-β1 in Parkinson's Disease.
Yao L; Lu F; Koc S; Zheng Z; Wang B; Zhang S; Skutella T; Lu G
Adv Sci (Weinh); 2023 Oct; 10(30):e2303711. PubMed ID: 37672887
[TBL] [Abstract][Full Text] [Related]
10. High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation.
Bonnet-Magnaval F; Diallo LH; Brunchault V; Laugero N; Morfoisse F; David F; Roussel E; Nougue M; Zamora A; Marchaud E; Tatin F; Prats AC; Garmy-Susini B; DesGroseillers L; Lacazette E
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008641
[TBL] [Abstract][Full Text] [Related]
11. Platelet TSP-1 controls prostate cancer-induced osteoclast differentiation and bone marrow-derived cell mobilization through TGFβ-1.
Kerr BA; Harris KS; Shi L; Willey JS; Soto-Pantoja DR; Byzova TV
Am J Clin Exp Urol; 2021; 9(1):18-31. PubMed ID: 33816691
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondins and remodeling of the tumor microenvironment.
Stenina-Adognravi O; Muppala S; Gajeton J
Vessel Plus; 2018; 2():. PubMed ID: 32984773
[TBL] [Abstract][Full Text] [Related]
13. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
14. Plasticity of patient-matched normal mammary epithelial cells is dependent on autologous adipose-derived stem cells.
Kengelbach-Weigand A; Tasbihi K; Strissel PL; Schmid R; Marques JM; Beier JP; Beckmann MW; Strick R; Horch RE; Boos AM
Sci Rep; 2019 Jul; 9(1):10722. PubMed ID: 31341222
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the complex role of thrombospondin-1 in glioblastoma development.
Daubon T; Léon C; Clarke K; Andrique L; Salabert L; Darbo E; Pineau R; Guérit S; Maitre M; Dedieu S; Jeanne A; Bailly S; Feige JJ; Miletic H; Rossi M; Bello L; Falciani F; Bjerkvig R; Bikfalvi A
Nat Commun; 2019 Mar; 10(1):1146. PubMed ID: 30850588
[TBL] [Abstract][Full Text] [Related]
16. Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.
Zhao C; Isenberg JS; Popel AS
J Cell Mol Med; 2018 Apr; 22(4):2086-2097. PubMed ID: 29441713
[TBL] [Abstract][Full Text] [Related]
17. Microenvironmental regulation of tumour angiogenesis.
De Palma M; Biziato D; Petrova TV
Nat Rev Cancer; 2017 Aug; 17(8):457-474. PubMed ID: 28706266
[TBL] [Abstract][Full Text] [Related]
18. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anticancer activity of valproate combined with nicotinamide enhances anti-proliferation response and apoptosis in MIAPaca2 cells.
Jafary H; Ahmadian S; Soleimani M
Mol Biol Rep; 2014 Jun; 41(6):3801-12. PubMed ID: 24595447
[TBL] [Abstract][Full Text] [Related]
20. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.
Grahovac J; Wells A
Lab Invest; 2014 Jan; 94(1):31-40. PubMed ID: 24247562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]